Company · CIK 1800315

# Damora Therapeutics, Inc.

| CIK | [1800315](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001800315) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | DMRA (Nasdaq) |
| First annual or quarterly report | 2020-12-11 |

## Offerings

 4 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-292175 | Shelf Effective | 2025-12-16 | 2026-08-12 | 3 |
| 333-293343 | Shelf Effective | 2026-02-10 | 2026-02-11 | 3 |
| 333-260778 | Shelf Effective | 2021-11-04 | 2023-03-09 | 4 |
| 333-249369 | IPO Final prospectus | 2020-10-07 | 2020-10-30 | 4 |

## Filings

 15

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-08-12 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1800315/999999999526002630/9999999995-26-002630-index.htm) Declared effective | 333-292175 | 9999999995-26-002630 |
| 2026-02-11 | [424B5](https://www.sec.gov/Archives/edgar/data/1800315/000119312526046779/0001193125-26-046779-index.htm) Shelf takedown | 333-293343 | 0001193125-26-046779 |
| 2026-02-10 | [424B5](https://www.sec.gov/Archives/edgar/data/1800315/000119312526044766/0001193125-26-044766-index.htm) Shelf takedown | 333-293343 | 0001193125-26-044766 |
| 2026-02-10 | [S-3ASR](https://www.sec.gov/Archives/edgar/data/1800315/000119312526044613/0001193125-26-044613-index.htm) Shelf registered | 333-293343 | 0001193125-26-044613 |
| 2025-12-23 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1800315/999999999525003922/9999999995-25-003922-index.htm) Declared effective | 333-292175 | 9999999995-25-003922 |
| 2025-12-16 | [S-3](https://www.sec.gov/Archives/edgar/data/1800315/000119312525321093/0001193125-25-321093-index.htm) Shelf registered | 333-292175 | 0001193125-25-321093 |
| 2023-03-09 | [424B5](https://www.sec.gov/Archives/edgar/data/1800315/000095017023006820/0000950170-23-006820-index.htm) Shelf takedown | 333-260778 | 0000950170-23-006820 |
| 2022-02-18 | [424B5](https://www.sec.gov/Archives/edgar/data/1800315/000156459022005716/0001564590-22-005716-index.htm) Shelf takedown | 333-260778 | 0001564590-22-005716 |
| 2021-11-12 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1800315/999999999521004331/9999999995-21-004331-index.htm) Declared effective | 333-260778 | 9999999995-21-004331 |
| 2021-11-04 | [S-3](https://www.sec.gov/Archives/edgar/data/1800315/000156459021054556/0001564590-21-054556-index.htm) Shelf registered | 333-260778 | 0001564590-21-054556 |
| 2020-10-30 | [424B4](https://www.sec.gov/Archives/edgar/data/1800315/000119312520282633/0001193125-20-282633-index.htm) Final prospectus | 333-249369 | 0001193125-20-282633 |
| 2020-10-28 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1800315/999999999520003010/9999999995-20-003010-index.htm) Declared effective | 333-249369 | 9999999995-20-003010 |
| 2020-10-22 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1800315/000119312520273986/0001193125-20-273986-index.htm) Amendment | 333-249369 | 0001193125-20-273986 |
| 2020-10-07 | [S-1](https://www.sec.gov/Archives/edgar/data/1800315/000119312520265628/0001193125-20-265628-index.htm) Registration filed | 333-249369 | 0001193125-20-265628 |
| 2020-09-02 | [DRS](https://www.sec.gov/Archives/edgar/data/1800315/000095012320009492/0000950123-20-009492-index.htm) Draft made public | 377-03490 | 0000950123-20-009492 |

[All filings of this company](https://equitycapital.markets/filings?cik=1800315) · [CSV](https://equitycapital.markets/filings.csv?cik=1800315)

---
Source page: https://equitycapital.markets/company/1800315 · Data: U.S. SEC EDGAR · CC BY 4.0